These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 37863324)
21. LncRNA LINC00680 promotes lung adenocarcinoma growth via binding to GATA6 and canceling GATA6-mediated suppression of SOX12 expression. Sun X; Wang R; Tan M; Tian X; Meng J Exp Cell Res; 2021 Aug; 405(1):112653. PubMed ID: 34029572 [TBL] [Abstract][Full Text] [Related]
22. DNA repair/recombination protein 54L promotes the progression of lung adenocarcinoma by activating mTORC1 pathway. Liu C; Ren W; Zhang Z; Guan J Hum Cell; 2023 Jan; 36(1):421-433. PubMed ID: 36454390 [TBL] [Abstract][Full Text] [Related]
23. E2F transcription factor 8 promotes proliferation and radioresistance in glioblastoma. Yu H; Zhang D; Li Z; Wang M Pathol Res Pract; 2020 Aug; 216(8):153030. PubMed ID: 32703494 [TBL] [Abstract][Full Text] [Related]
24. MiR-340-3p-HUS1 axis suppresses proliferation and migration in lung adenocarcinoma cells. Ren K; Yu Y; Wang X; Liu H; Zhao J Life Sci; 2021 Jun; 274():119330. PubMed ID: 33711383 [TBL] [Abstract][Full Text] [Related]
25. Junctional adhesion molecule-like protein as a novel target for kaempferol to ameliorate lung adenocarcinoma. Wu Q; Wang YB; Che XW; Wang H; Wang W J Integr Med; 2023 May; 21(3):268-276. PubMed ID: 37069006 [TBL] [Abstract][Full Text] [Related]
26. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway. Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133 [TBL] [Abstract][Full Text] [Related]
27. Histone lysine methyltransferase SETDB2 suppresses NRF2 to restrict tumor progression and modulates chemotherapy sensitivity in lung adenocarcinoma. Yuan G; Hu B; Ma J; Zhang C; Xie H; Wei T; Yang Y; Ni B Cancer Med; 2023 Mar; 12(6):7258-7272. PubMed ID: 36504353 [TBL] [Abstract][Full Text] [Related]
28. The impact of SOX4-activated CTHRC1 transcriptional activity regulating DNA damage repair on cisplatin resistance in lung adenocarcinoma. Ai C; Huang Z; Rong T; Shen W; Yang F; Li Q; Bi L; Li W Electrophoresis; 2024 Aug; 45(15-16):1408-1417. PubMed ID: 38629299 [TBL] [Abstract][Full Text] [Related]
29. Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma. Li S; Li H; Cao Y; Geng H; Ren F; Li K; Dai C; Li N Medicine (Baltimore); 2021 Aug; 100(32):e26474. PubMed ID: 34397869 [TBL] [Abstract][Full Text] [Related]
30. Transcriptomic analysis of tumor tissues and organoids reveals the crucial genes regulating the proliferation of lung adenocarcinoma. Ma X; Yang S; Jiang H; Wang Y; Xiang Z J Transl Med; 2021 Aug; 19(1):368. PubMed ID: 34446056 [TBL] [Abstract][Full Text] [Related]
31. LncRNA LINC00511 promotes COL1A1-mediated proliferation and metastasis by sponging miR-126-5p/miR-218-5p in lung adenocarcinoma. Wang Y; Mei X; Song W; Wang C; Qiu X BMC Pulm Med; 2022 Jul; 22(1):272. PubMed ID: 35842617 [TBL] [Abstract][Full Text] [Related]
32. Loss of RPS27a expression regulates the cell cycle, apoptosis, and proliferation via the RPL11-MDM2-p53 pathway in lung adenocarcinoma cells. Li H; Zhang H; Huang G; Bing Z; Xu D; Liu J; Luo H; An X J Exp Clin Cancer Res; 2022 Jan; 41(1):33. PubMed ID: 35073964 [TBL] [Abstract][Full Text] [Related]
33. Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma. Li MX; Zhang MY; Dong HH; Li AJ; Teng HF; Liu AL; Xu N; Qu YQ Int J Med Sci; 2021; 18(2):494-504. PubMed ID: 33390818 [No Abstract] [Full Text] [Related]
34. Inactivation of Rb and E2f8 synergizes to trigger stressed DNA replication during erythroid terminal differentiation. Ghazaryan S; Sy C; Hu T; An X; Mohandas N; Fu H; Aladjem MI; Chang VT; Opavsky R; Wu L Mol Cell Biol; 2014 Aug; 34(15):2833-47. PubMed ID: 24865965 [TBL] [Abstract][Full Text] [Related]
35. MNT inhibits lung adenocarcinoma ferroptosis and chemosensitivity by suppressing SAT1. Zhao G; Liang J; Zhang Y; Shan G; Bian Y; Gu J; Zhan C; Ge D Commun Biol; 2024 Jun; 7(1):680. PubMed ID: 38831092 [TBL] [Abstract][Full Text] [Related]
36. E2F8 as a Novel Therapeutic Target for Lung Cancer. Park SA; Platt J; Lee JW; López-Giráldez F; Herbst RS; Koo JS J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26089541 [TBL] [Abstract][Full Text] [Related]
37. Sauchinone: a prospective therapeutic agent-mediated EIF4EBP1 down-regulation suppresses proliferation, invasion and migration of lung adenocarcinoma cells. Li SQ; Feng J; Yang M; Ai XP; He M; Liu F J Nat Med; 2020 Sep; 74(4):777-787. PubMed ID: 32666278 [TBL] [Abstract][Full Text] [Related]
38. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A. Zhao W; Xie Y Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400 [TBL] [Abstract][Full Text] [Related]
39. PRMT6 serves an oncogenic role in lung adenocarcinoma via regulating p18. Tang J; Meng Q; Shi R; Xu Y Mol Med Rep; 2020 Oct; 22(4):3161-3172. PubMed ID: 32945431 [TBL] [Abstract][Full Text] [Related]
40. LncRNA PCBP1-AS1 correlated with the functional states of cancer cells and inhibited lung adenocarcinoma metastasis by suppressing the EMT progression. Li Z; Pan C; Wang Z; Deng X; Zhu Q; Wu W; Chen L Carcinogenesis; 2021 Jul; 42(7):931-939. PubMed ID: 34107009 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]